pain. Pain, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: Patients in the intervention Group received intravenous MgSO4 at 50 mg/kg diluted in 100 ml of normal saline over 15 minutes with intravenous acetaminophen 15 m
Sponsors
CMH Rawalpindi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: all ASA-I and II patients diagnosed with asthma by spirometry pre- and post-bronchodilator therapy with confirmation of reversibility presenting to the surgical department for elective laparoscopic cholecystectomy compliant and optimized on treatment.
Exclusion criteria
Exclusion criteria: major cardiac or respiratory disease low ejection fraction unoptimized for hypertension or diabetes patients with cholecystitis, patients allergic to acetaminophen, MgSO4, lignocaine or nalbuphine patient with a history of asthma exacerbation requiring admission in the last 8 weeks. patients on oral or intravenous steroids for asthma patients unwilling to be included in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analgesia. Timepoint: 24hrs after first analgesics dose. Method of measurement: Visual Analogue Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Hypotension. Timepoint: 1,3,6 hours. Method of measurement: cardiac monitor, sphygmomanometer.;Respiratory depression. Timepoint: 1,3,6 hours. Method of measurement: pulse oximetry, cardiac monitor.;Nausea. Timepoint: 1,3,6 hours. Method of measurement: Visual assessment and patient complaints.;Vomiting. Timepoint: 1,3,6 hours. Method of measurement: Clinical assessment, patient complaints. | — |
Countries
Pakistan
Contacts
Public ContactSaddam Hussain
CMH Rawalpindi
Outcome results
None listed